Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm

NEW YORK, July 25, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.

If you own ZNTL please contact Moon Young by email at [e-mail] or call [phone]. The consultation and case are free with no obligation to you. Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights. 

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™

For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
[e-mail]
[phone]

View original content to download multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-zentalis-pharmaceuticals-inc-to-contact-law-firm-302206787.html

SOURCE Kuehn Law, PLLC

Copyright 2024 PR Newswire